The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support

Thu, 05th Nov 2020 09:24

(Alliance News) - Stock prices in London were in the green early on Thursday, as investors took heart from the Bank of England boosting quantitative easing in the hopes of easing pressure on the UK's Covid-19 hit economy.

The UK central bank on Thursday kept interest rates on hold, as expected, but upped QE by GBP150 billion, a bit more than anticipated, taking its total stock of UK government bond purchases to GBP875 billion.

The pound was quoted at USD1.3015 early on Thursday, improved from USD1.2977 on Wednesday evening.

"Stocks on the FTSE are being supported after the Bank of England announced that it will pump an additional GBP150 billion into the economy as the UK goes into lockdown," said Gain Capital analyst Fiona Cincotta.

She added: "The pound breathed a sigh of relief; early morning rumours had suggested that the BoE was going to cut rates which had sent the pound sharply lower."

The FTSE 100 index of London large-cap stocks was up 8.04 points, or 0.1% at 5,891.30. The blue-chip index had risen as much as 0.6% to 5,916.27 earlier on Thursday morning before giving back some of that gain.

The FTSE 250 rose 54.99 points, or 0.3%, at 17,851.07. The AIM All-Share was up 1.05 points, 0.1%, at 975.79.

The Cboe UK 100 index was up 0.1% at 584.79. The Cboe 250 was up 0.4% at 15,014.49. The Cboe Small Companies lost 0.2% at 9,607.24.

The CAC 40 stock index in Paris rose 0.9% in early trade on Wednesday, and Frankfurt's DAX 30 was up 1.1%.

The euro improved to USD1.1757, from USD1.1710 at the European market close on Wednesday.

The US presidential election remains undecided. Joe Biden has 264 electoral college votes versus Trump's 214, with 270 votes required to win. However, Trump has requested recounts in several states and threatens legal action.

"On paper this was the worst-case scenario, an undecided, contested Presidential election. The reality is that the market couldn't seem happier with the most likely outcome of a Democrat President, and Republican Senate," said Cincotta, adding: "This is because Joe Biden's tax [hikes] are unlikely to be passed by a Republican Senate. Gridlock in Capitol Hill on this occasion could be good news for stocks."

Versus the Japanese yen, the dollar was at JPY104.31, down from JPY104.49 at the London market close on Wednesday.

On the London Stock Exchange, AstraZeneca left annual guidance unchanged after posting a 3% third-quarter revenue hike. Its shares were up 0.2% in early trading.

Revenue in the quarter amounted to USD6.58 billion, taking revenue for the nine-month period to USD19.21 billion, 8% higher annually on a reported basis, or 10% at constant currency.

"We made encouraging headway in the quarter, despite the ongoing disruption from the COVID-19 pandemic. Highlights of the sales performance included further success in Oncology and an acceleration in the progress of Farxiga," Chief Executive Officer Pascal Soriot said.

Looking ahead, annual revenue is still expected to grow by a "high single-digit to a low double-digit percentage" at constant currency.

Peer Hikma rose 1.6%. The pharmaceutical firm hailed "positive momentum in the first half".

Its Injectables unit saw less demand for Covid-19 related products so far in the second half of the year, compared to the first, though it backed the unit to achieve revenue between USD950 million and USD980 million.

Hikma lifted guidance at its Generics arm, however, expecting revenue between USD720 million and USD740 million, up from the previous range of USD710 million and USD730 million.

"Following a strong first half, our Generics business continues to perform well, supported by a better than expected contribution from new launches and strong demand across our differentiated portfolio," Hikma explained.

Supermarket chain Sainsbury's sat towards the bottom of the FTSE 100, down 2.8%. It sunk to a GBP137 million interim pretax loss, from a GBP9 million profit a year earlier. The company was hit by a bruising GBP438 million in one-off costs.

Group sales, excluding VAT but including fuel, inched 1.1% lower to GBP14.93 billion from GGBP15.10 billion. Like-for-like sales excluding fuel jumped 6.9% annually, however.

"Sales during the first half were stronger than the base case assumptions we outlined in April, particularly at Argos, driving a strong underlying profit increase against a soft comparative base," the company said.

Commenting on the lockdown that has gone into effect on Thursday in England, which doesn't close grocery stores and limits competition from restaurants, Sainsbury's said: "We cannot fully predict the impact of COVID-19 and lockdown restrictions on retail sales and costs for the remainder of the second half of the year, but our current assumptions would result in full year group underlying profit before tax increasing by at least 5% year-on-year."

Looking further ahead, the company said it will close around 420 Argos standalone stores, reducing the standalone estate to just 100 by March 2024. However, it will open 150 more Argos stores in Sainsbury's supermarkets by the target date, as well as 150 to 200 more Argos collection points in supermarkets and convenience stores.

Sainsbury confirmed that as part of its cost-cutting plans, "around 3,500" jobs could be lost. This is higher than the 3,000 job cuts reported by UK media outlets ahead of Thursday's results announcement. "We will do everything possible to find alternative roles for our colleagues," Sainsbury's said.

Elsewhere among the blue-chips, Homeserve was up 4.7%, the best performer, after Credit Suisse resumed coverage of the emergency home repairs business with an Outperform rating.

Away from the large-caps, N Brown shares dropped 6.3%. The retailer's revenue fell 18% to GBP356.7 million, and its pretax profit dropped by a quarter to GBP14.1 million in the six months ended August 31, a period hit by Covid-19 lockdowns.

With more curbs to come in England, N Brown said it will bolster its coffers through a GBP100 million placing and open offer.

The company also plans to delist from the London Main Market and move to the junior AIM market.

N Brown said AIM is a more "appropriate environment" and better suited for a company of its size.

Gold was quoted at USD1,918.02 early on Thursday in London, up from USD1,901.50 late Wednesday.

A barrel of Brent fetched USD40.86, up from USD40.62.

The economic calendar on Thursday has a UK Markit construction PMI at 0930 GMT. Eurozone retail sales are due at 1000 GMT and the weekly US initial jobless claims are out at 1330 GMT.

In the US, the Federal Open Market Committee will conclude its two-day policy meeting on Thursday and announce its decision at 1900 GMT. This will be followed by a press conference with Fed Chair Jerome Powell at 1930 GMT.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
5 Aug 2022 09:43

Barclays downgrades Hikma to 'equalweight' on Generics concerns

(Sharecast News) - Barclays downgraded Hikma Pharmaceuticals on Friday to 'equalweight' from 'overweight' and cut the price target to 1,750p from 2,250p as it said a lack of visibility in the generics division was a real concern.

Read more
5 Aug 2022 08:15

LONDON BRIEFING: London Stock Exchange benefits from market volatility

(Alliance News) - London Stock Exchange Group on Friday said results in the first half of 2022 improved, as this year's interim period had an extra month's worth of contribution from recent acquisition Refinitiv.

Read more
4 Aug 2022 17:05

LONDON MARKET CLOSE: Stocks shrug off BoE's UK recession warning

(Alliance News) - Stocks in London managed to end higher on Thursday despite a bleak warning from the Bank of England regarding to outlook for the UK economy as it jacked up rates by 50 basis points.

Read more
4 Aug 2022 12:09

LONDON MARKET MIDDAY: BoE hikes, expects UK recession in 4th quarter

(Alliance News) - London shares price made some gains on Thursday morning, though these fell well short of the market rise seen on mainland Europe, as traders in London showed signs of trepidation leading up to the Bank of England's interest rate decision.

Read more
4 Aug 2022 10:15

Hikma revenue flat, profits tumble in first half

(Sharecast News) - Hikma shares were tumbling on Thursday morning after the pharmaceuticals company reported flat group revenue in its first half, at $1.21bn, as it slashed its guidance on its lagging generics business.

Read more
4 Aug 2022 09:01

LONDON MARKET OPEN: FTSE 100 underperforms amid pre-BoE trepidation

(Alliance News) - The FTSE 100 underperformed European peers and traded sideways in early dealings on Thursday, with the Bank of England to take centre-stage during a week that so far has been dominated by tensions between the US and China.

Read more
4 Aug 2022 09:00

TOP NEWS: Hikma first half hit by stiff competition for Generics

(Alliance News) - Hikma Pharmaceuticals PLC shares suffered on Thursday, as it lowered annual guidance after a poor performance in its Generics business hit half-year profit.

Read more
4 Aug 2022 07:54

LONDON MARKET PRE-OPEN: Next and Serco up outlook but Hikma lowers

(Alliance News) - Stock prices in London are seen opening ever-so-slightly higher, falling short of the more convincing gains seen in Asia, with investors wary ahead of the latest Bank of England interest rate decision.

Read more
28 Jul 2022 16:06

UK earnings, trading statements calendar - next 7 days

Friday 29 July 
Allianz Technology Trust PLCHalf Year Results
Aston Martin Lagonda Global Holdings PLCHalf Year Results
AstraZeneca PLCHalf Year Results
Babcock International Group PLCFull Year Results
CMC Markets PLCTrading Statement
Croda International PLCHalf Year Results
Glencore PLCTrading Statement
Jupiter Fund Management PLCHalf Year Results
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
Industrials REIT LtdTrading Statement
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Law Debenture Corp PLCHalf Year Results
Morgan Advanced Materials PLCHalf Year Results
NatWest Group PLCHalf Year Results
Premier Miton Global Renewables Trust PLCHalf Year Results
Rightmove PLCHalf Year Results
Shearwater Group PLCFull Year Results
Standard Chartered PLCHalf Year Results
Walker Crips Group PLCFull Year Results
YouGov PLCTrading Statement
Monday 1 August 
Ascential PLCHalf Year Results
Cranswick PLCQ1 Results
Dialight PLCHalf Year Results
GlobalData PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
NAHL Group PLCTrading Statement
Pearson PLCHalf Year Results
Senior PLCHalf Year Results
Seraphine Group PLCFull Year Results
Spectris PLCHalf Year Results
XP Power PLCHalf Year Results
Tuesday 2 August 
BP PLCHalf Year Results
Capital & Counties Properties PLCHalf Year Results
Coats Group PLCHalf Year Results
Devro PLCHalf Year Results
Direct Line Insurance Group PLCHalf Year Results
Domino's Pizza Group PLCHalf Year Results
Fresnillo PLCHalf Year Results
Greggs PLCHalf Year Results
Keller Group PLCHalf Year Results
Man Group PLCHalf Year Results
Rotork PLCHalf Year Results
Sage Group PLCQ3 Results
Staffline Group PLCHalf Year Results
Synthomer PLCHalf Year Results
Travis Perkins PLCHalf Year Results
Virgin Money UK PLCQ3 Results
Wednesday 3 August 
Endeavour Mining PLCHalf Year Results
Ferrexpo PLCHalf Year Results
Hill & Smith Holdings PLCHalf Year Results
Hiscox LtdHalf Year Results
IP Group PLCHalf year Results
LSL Property Services PLCHalf Year Results
Taylor Wimpey PLCHalf Year Results
Thursday 4 August 
Coca-Cola Europacific Partners PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Evraz PLCHalf Year Results
Glencore PLCHalf Year Results
Gym Group PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Meggitt PLCHalf Year Results
Mondi PLCHalf Year Results
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Pantheon International PLCFull Year Results
Revolution Beauty Group PLCFull Year Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Secure Trust Bank PLCHalf Year Results
Serco Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 Jul 2022 09:46

LONDON BROKER RATINGS: Trio of downgrades for Fevertree; Admiral cut

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
13 Jul 2022 10:02

LONDON BROKER RATINGS: Jefferies likes Tyman; UBS cuts Beazley

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 10:05

LONDON BROKER RATINGS: JPMorgan cuts Hikma; Liberum likes Trustpilot

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 08:28

LONDON BRIEFING: M&S warns on cost hit to profit but is well placed

(Alliance News) - Marks & Spencer on Wednesday reported a swing to profit for the year ended April 2, but the clothing, homewares and food retailer cautioned on profit in the year ahead, amid the war in Ukraine and investment plans.

Read more
24 May 2022 10:29

IN BRIEF: Hikma Pharmaceuticals Chief Executive Siggi Olafsson resigns

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Says Siggi Olafsson has resigned as chief executive officer and from the board to "pursue other opportunities." Adds he will remain available to the company until he resigns on June 24. Olafsson was appointed as CEO in 2018. Before he joined Hikma, he was president of peer firm Actavis Generics until 2014 from 2012.

Read more
24 May 2022 08:24

LONDON BRIEFING: Barclays launches delayed GBP1 billion share buyback

(Alliance News) - Barclays said it will kick off a GBP1.00 billion share buyback programme on Tuesday. The programme, initially announced in February, had been delayed in March after the bank admitted it sold more financial products to investors than it was allowed to.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.